CY1114850T1 - Αντικαρκινικη ενωση και η φαρμακευτικη συνθεση που την περιεχει - Google Patents

Αντικαρκινικη ενωση και η φαρμακευτικη συνθεση που την περιεχει

Info

Publication number
CY1114850T1
CY1114850T1 CY20131100920T CY131100920T CY1114850T1 CY 1114850 T1 CY1114850 T1 CY 1114850T1 CY 20131100920 T CY20131100920 T CY 20131100920T CY 131100920 T CY131100920 T CY 131100920T CY 1114850 T1 CY1114850 T1 CY 1114850T1
Authority
CY
Cyprus
Prior art keywords
cancer
union
pharmaceutical composition
composition containing
compound
Prior art date
Application number
CY20131100920T
Other languages
English (en)
Inventor
Jean-Christophe Carry
Michel Cheve
François Clerc
Cécile Combeau
Sylvie Gontier
Alain Krick
Sylvette Lachaud
Laurent Schio
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of CY1114850T1 publication Critical patent/CY1114850T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση σχετίζεται με την ένωση του τύπου (Ι) : πιο συγκεκριμένα με την αριστερόστροφη μορφή της (la), κυρίως αυτή που παρουσιάζει την περιστροφική ισχύ [[άλφα]] = -38,6+0,7 σε μια συγκέντρωση από 0,698 mg/ml μέσα σε μεθανόλη. Η ένωση μπορεί να υπάρχει με τη μορφή βάσης ή ενός άλατος προσθήκης σε ένα οξύ, κυρίως σε ένα φαρμακευτικώς αποδεκτό οξύ. Η ένωση αυτή είναι ένας επιλεκτικός αναστολέας των κινάσεων Αurora A και Β. Μπορεί να χρησιμοποιηθεί ως αντικαρκινικός παράγοντας.
CY20131100920T 2009-05-18 2013-10-17 Αντικαρκινικη ενωση και η φαρμακευτικη συνθεση που την περιεχει CY1114850T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0902392A FR2945535B1 (fr) 2009-05-18 2009-05-18 Compose anticancereux et composition pharmaceutique le contenant
EP10728768.2A EP2432766B1 (fr) 2009-05-18 2010-05-17 Composé anticancéreux et composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
CY1114850T1 true CY1114850T1 (el) 2016-12-14

Family

ID=40973187

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100920T CY1114850T1 (el) 2009-05-18 2013-10-17 Αντικαρκινικη ενωση και η φαρμακευτικη συνθεση που την περιεχει

Country Status (35)

Country Link
US (2) US9073917B2 (el)
EP (1) EP2432766B1 (el)
JP (1) JP5656981B2 (el)
KR (1) KR20120032483A (el)
CN (1) CN102459193B (el)
AR (1) AR076686A1 (el)
AU (1) AU2010251013B2 (el)
BR (1) BRPI1012201A2 (el)
CA (1) CA2762233C (el)
CL (1) CL2011002930A1 (el)
CO (1) CO6400138A2 (el)
CY (1) CY1114850T1 (el)
DK (1) DK2432766T3 (el)
EA (1) EA021084B1 (el)
ES (1) ES2430989T3 (el)
FR (1) FR2945535B1 (el)
HK (1) HK1167388A1 (el)
HR (1) HRP20130959T1 (el)
IL (1) IL216361A0 (el)
JO (1) JO2852B1 (el)
MA (1) MA33356B1 (el)
ME (1) ME01542B (el)
MX (1) MX2011012356A (el)
MY (1) MY152995A (el)
NZ (1) NZ596464A (el)
PL (1) PL2432766T3 (el)
PT (1) PT2432766E (el)
RS (1) RS53002B (el)
SG (1) SG176169A1 (el)
SI (1) SI2432766T1 (el)
SM (1) SMT201400005B (el)
TW (1) TWI441822B (el)
UY (1) UY32644A (el)
WO (1) WO2010133794A1 (el)
ZA (1) ZA201108447B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945535B1 (fr) 2009-05-18 2011-06-10 Sanofi Aventis Compose anticancereux et composition pharmaceutique le contenant
FR2967413A1 (fr) * 2010-11-17 2012-05-18 Sanofi Aventis Compose 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)-phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate d'ethyle, sel, forme cristalline, co-cristal, formulation, procedes de preparation, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteur des kinases aurora.
PT2909204T (pt) 2012-10-12 2019-03-21 Dana Farber Cancer Inst Inc Inibidores de gsk3 e métodos de utilização dos mesmos
EP3164388A1 (en) 2014-07-01 2017-05-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors
CN110958882B (zh) 2017-04-05 2023-08-29 布罗德研究所股份有限公司 作为糖原合酶激酶3(gsk3)抑制剂的三环化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02005016A (es) 1999-11-19 2003-01-28 Abbott Lab Abridores de canal de potasio de dihidropirimidina triciclica.
KR20030076650A (ko) 2001-02-02 2003-09-26 미쯔비시 웰 파마 가부시키가이샤 디하이드로피라졸로피리딘 화합물 및 그의 약학적 용도
US7037902B2 (en) 2002-07-03 2006-05-02 Receptron, Inc. Affinity small molecules for the EPO receptor
CA2528938A1 (en) * 2003-06-13 2005-02-24 Zentaris Gmbh Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
SI1746097T1 (sl) 2005-07-20 2010-05-31 Aventis Pharma Sa dihidropiridin kondenzirani heterocikli postopek za njihovo pripravo njihova uporaba in sestavki ki jih vsebujejo
FR2945535B1 (fr) 2009-05-18 2011-06-10 Sanofi Aventis Compose anticancereux et composition pharmaceutique le contenant

Also Published As

Publication number Publication date
MX2011012356A (es) 2011-12-14
WO2010133794A1 (fr) 2010-11-25
JP5656981B2 (ja) 2015-01-21
DK2432766T3 (da) 2013-10-28
EP2432766B1 (fr) 2013-07-17
JO2852B1 (en) 2015-03-15
MA33356B1 (fr) 2012-06-01
HK1167388A1 (en) 2012-11-30
US9221817B2 (en) 2015-12-29
EP2432766A1 (fr) 2012-03-28
SG176169A1 (en) 2011-12-29
NZ596464A (en) 2014-01-31
CN102459193B (zh) 2014-08-27
CA2762233C (fr) 2017-11-28
SI2432766T1 (sl) 2013-11-29
MY152995A (en) 2014-12-31
CA2762233A1 (fr) 2010-11-25
AR076686A1 (es) 2011-06-29
HRP20130959T1 (hr) 2013-11-22
FR2945535B1 (fr) 2011-06-10
KR20120032483A (ko) 2012-04-05
US20120220621A1 (en) 2012-08-30
ME01542B (me) 2014-04-20
EA021084B1 (ru) 2015-04-30
TW201100418A (en) 2011-01-01
RS53002B (en) 2014-04-30
EA201171429A1 (ru) 2012-05-30
CL2011002930A1 (es) 2012-06-29
UY32644A (es) 2010-12-31
CN102459193A (zh) 2012-05-16
AU2010251013A1 (en) 2011-12-08
FR2945535A1 (fr) 2010-11-19
PL2432766T3 (pl) 2013-12-31
TWI441822B (zh) 2014-06-21
ES2430989T3 (es) 2013-11-22
BRPI1012201A2 (pt) 2016-04-05
CO6400138A2 (es) 2012-03-15
IL216361A0 (en) 2012-01-31
JP2012527436A (ja) 2012-11-08
PT2432766E (pt) 2013-10-23
US9073917B2 (en) 2015-07-07
SMT201400005B (it) 2014-03-07
AU2010251013B2 (en) 2015-08-20
ZA201108447B (en) 2013-01-30
US20150266877A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
NO2016021I1 (no) 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2Hpyrido[2,3-D]pyrimidinderivater og relaterte forbindelser for behandling av kreft
CY1119730T1 (el) Παραγωγα καρβοξυλικου οξεος πυρρολιδινης ως αγωνιστες του συζευγμενου με πρωτεϊνή-g υποδοχεα 43 (gpr43), φαρμακευτικη συνθεση και μεθοδοι για χρηση στην αντιμετωπιση μεταβολικων διαταραχων
CY1114850T1 (el) Αντικαρκινικη ενωση και η φαρμακευτικη συνθεση που την περιεχει
CY1114092T1 (el) Σπειρο υποκατεστημενες ενωσεις ως αναστολεις αγγειογενεσης
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
CY1112401T1 (el) Παραγωγα πυριδαζινης
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
EA200970156A1 (ru) Пиридизиноновые производные
BR122013025375B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
CY1108292T1 (el) Αντικαρκινικο σκευασμα που περιεχει dmxaa
ATE507212T1 (de) Morpholine als 5ht2c-agonisten
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
EA200700601A1 (ru) Производные фениламинопиримидина как ингибиторы bcr-abl
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
EA201071329A1 (ru) Диамидные производные адамантана и их применение
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
CY1122084T1 (el) Συνθεσεις που περιλαμβανουν αμλοδιπινη και μπισοπρολολη
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
NO20085317L (no) Imidazoazepinonforbindelser
ECSP099442A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
CY1113240T1 (el) Αλατα ενωσεων αναστολεα hiv